Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update
JournalJournal of Analytical Toxicology
PublisherOxford University Press
MetadataShow full item record
AbstractThis report describes the outcomes of a process undertaken to review and update the National Safety Council's Alcohol, Drugs and Impairment Division's recommendations for the toxicological investigation of suspected alcohol and drug-impaired driving cases and motor vehicle fatalities. The updates to the recommendations are made based on a survey of practices in laboratories in the USA and Canada performing testing in these cases, consideration of existing epidemiological crash and arrest data, current drug use patterns, and practical considerations of widely available technology platforms in laboratories performing this work. The final recommendations updates are derived from a consensus meeting of experts recruited from survey respondents and the membership of the National Safety Council's Alcohol, Drug and Impairment Division. The principal changes in this round of recommendations include removal of butalbital, phenobarbital, and phencyclidine from Tier I (mandatory) to Tier II (optional) due to changes in prevalence. In addition, buprenorphine, fentanyl, tramadol, and their metabolites were moved from Tier II to Tier I due to increased prevalence and concerns about their potential for causing impairment. In addition, screening and confirmatory cutoffs for the oral fluid scope were further refined. Other additions were made to the list of Tier II compounds including fentanyl analogs (e.g., acetylfentanyl, butyrylfentanyl, furanylfentanyl, etc), mitragynine, novel opioids (e.g., MT-45, U- 47700), atypical antipsychotics, and novel benzodiazepines (e.g., clonazolam, flubromazolam, etc). Copyright The Author 2017. Published by Oxford University Press. All rights reserved.
SponsorsFunding for this project was provided by the National Safety Council under contract # DTNH22-15-H-00473.
KeywordNational Safety Council. Alcohol, Drugs, and Impairment Division
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85043334840&doi=10.1093%2fjat%2fbkx082&partnerID=40&md5=fd10815321e33504f0f49bfa855ae22b; http://hdl.handle.net/10713/9483
- Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities.
- Authors: Logan BK, Lowrie KJ, Turri JL, Yeakel JK, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Farrell LJ
- Issue date: 2013 Oct
- Carfentanil in Impaired Driving Cases and the Importance of Drug Seizure Data.
- Authors: Tiscione NB, Alford I
- Issue date: 2018 Sep 1
- Drugged Driving in Wisconsin: Oral Fluid Versus Blood.
- Authors: Edwards LD, Smith KL, Savage T
- Issue date: 2017 Jul 1
- Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.
- Authors: Lu A, Scott KS, Chan-Hosokawa A, Logan BK
- Issue date: 2017 Mar 1
- Recommendations for toxicological investigation of drug impaired driving.
- Authors: Farrell LJ, Kerrigan S, Logan BK
- Issue date: 2007 Sep